Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432
NCT01699347
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
5
Enrollment
OTHER
Sponsor class
Conditions
CYSTIC MALFORMATION
Interventions
DRUG:
Intracystic injection of OK432 under US guiding
Sponsor
Carmel Medical Center